About PharmAla Biotech
PharmAla Biotech is a company based in Toronto (Canada) founded in 2021. PharmAla Biotech offers products and services including LaNeo™ MDMA and Novel MDXX Compounds. PharmAla Biotech operates in a competitive market with competitors including MCRA, Blue Matter Consulting, CHDR, S-Cubed and CATALIS, among others.
- Headquarter Toronto, Canada
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pharmala Biotech Holdings, Inc.
-
Annual Revenue
$440.33 K (USD)-41.51as on Aug 31, 2025
-
Net Profit
-$1.59 M (USD)-164.12as on Aug 31, 2025
-
EBITDA
-$1.48 M (USD)-241.66as on Aug 31, 2025
-
Latest Funding Round
$1.09 M (USD), Post-IPO
Dec 20, 2024
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PharmAla Biotech
PharmAla Biotech is a publicly listed company on the CSE with ticker symbol MDMA in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of PharmAla Biotech
PharmAla Biotech offers a comprehensive portfolio of products and services, including LaNeo™ MDMA and Novel MDXX Compounds.
Clinical-grade MDMA for research and therapeutic applications.
Improved MDMA analogs to enhance safety for various disorders.
Funding Insights of PharmAla Biotech
Investments & Acquisitions by PharmAla Biotech
Investment portfolio details for PharmAla Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PharmAla Biotech
Detailed financials for PharmAla Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharmala Biotech Comparisons
Peer comparison for PharmAla Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PharmAla Biotech
PharmAla Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MCRA, Blue Matter Consulting, CHDR, S-Cubed and CATALIS, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of regulatory, quality assurance and market access services to biopharma sector
|
|
| Locked | Locked | Locked |
Provider of consulting services focused for clinical drug development
|
|
| Locked | Locked | Locked |
Early-stage clinical drug research consulting services are provided.
|
|
| Locked | Locked | Locked |
Specialized consulting in clinical biometrics and regulatory affairs is provided.
|
|
| Locked | Locked | Locked |
Consulting services for clinical drug development and trials are provided.
|
Detailed competitors of PharmAla Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharmala Biotech
Complete news archive for PharmAla Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PharmAla Biotech
PharmAla Biotech was founded in 2021 and raised its 1st funding round 2 years after it was founded.
PharmAla Biotech is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Annual revenue of PharmAla Biotech is $440.33K as on Aug 31, 2025.
PharmAla Biotech was founded in 2021 and is based in Toronto, Canada. Operations focus on the biotechnology sector, where biomanufacturing processes are supported alongside regulatory compliance and financial advisory services. These offerings assist clients in navigating production, approval, and funding challenges within the industry. The companys domain, pharmala.ca, serves as the primary online presence for these activities.
PharmAla Biotech's top competitors include S-Cubed, Vasta Global and Blue Matter Consulting.
PharmAla Biotech offers LaNeo™ MDMA and Novel MDXX Compounds.
Yes, PharmAla Biotech is publicly traded on CSE under the ticker symbol MDMA.
The ticker symbol of PharmAla Biotech is MDMA on CSE.